After 64 weeks, the maximum Wegovy pill dose has been shown to help people lose, on average, 16.6% of their starting body weight
Behavioral risks: Vaping perpetuates the hand-to-mouth behavior and reward cycle, making cessation more challenging in the future
To see my weight go down feels amazing
What factors could limit the widespread adoption of GLP-1 receptor agonists despite their proven benefits in HbA1c reduction, weight loss, and cardiovascular risk management, and how might healthcare systems address these barriers
[28] A 2014 meta-analysis found no evidence for increased pancreatic cancer risk in people treated with DPP-4 inhibitors, but owing to the modest amount of data available, the authors were unable to completely exclude possibly increased risk
It became increasingly sought because clinical tests and real-world results showed remarkable weight-lowering gains